Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgan

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Urogynecology (Philadelphia, Pa.)|July 25, 2023
Performance of Perioperative Tasks for Women Undergoing Anti-incontinence Surgery: Developed by the AUGS Quality Improvement and Outcomes Research NetworkElisabeth Erekson, Emily L Whitcomb, Neil Kamdar, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitorsAndrew P Degnan, George O Tora, Ying Han, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SARChristiana Iwuagwu, Dalton King, Ivar M McDonald, et al.
Infection Control and Hospital Epidemiology|April 9, 2014
The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for researchNasia Safdar, Deverick J Anderson, Barbara I Braun, et al.
European Journal of Pharmacology|April 26, 2017
Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodentsRick L Pieschl, Regina Miller, Kelli M Jones, et al.
JAMA Network Open|July 20, 2023
Implementation of a Prevention Bundle to Decrease Rates of Staphylococcus aureus Surgical Site Infection at 11 Veterans Affairs HospitalsHiroyuki Suzuki, Eli N Perencevich, Stacey Hockett Sherlock, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor AgonistsMatthew D Hill, Haiquan Fang, H Dalton King, et al.
Plos One|July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of SchizophreniaLinda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Genome Biology|March 9, 2023
The Network Zoo: a multilingual package for the inference and analysis of gene regulatory networksMarouen Ben Guebila, Tian Wang, Camila M Lopes-Ramos, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with SchizophreniaDalton King, Christiana Iwuagwu, Jim Cook, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Urogynecology (Philadelphia, Pa.)|July 25, 2023
Performance of Perioperative Tasks for Women Undergoing Anti-incontinence Surgery: Developed by the AUGS Quality Improvement and Outcomes Research NetworkElisabeth Erekson, Emily L Whitcomb, Neil Kamdar, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitorsAndrew P Degnan, George O Tora, Ying Han, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SARChristiana Iwuagwu, Dalton King, Ivar M McDonald, et al.
Infection Control and Hospital Epidemiology|April 9, 2014
The evolving landscape of healthcare-associated infections: recent advances in prevention and a road map for researchNasia Safdar, Deverick J Anderson, Barbara I Braun, et al.
European Journal of Pharmacology|April 26, 2017
Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodentsRick L Pieschl, Regina Miller, Kelli M Jones, et al.
JAMA Network Open|July 20, 2023
Implementation of a Prevention Bundle to Decrease Rates of Staphylococcus aureus Surgical Site Infection at 11 Veterans Affairs HospitalsHiroyuki Suzuki, Eli N Perencevich, Stacey Hockett Sherlock, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
Development of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor AgonistsMatthew D Hill, Haiquan Fang, H Dalton King, et al.
Plos One|July 29, 2016
The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of SchizophreniaLinda J Bristow, Amy E Easton, Yu-Wen Li, et al.
Genome Biology|March 9, 2023
The Network Zoo: a multilingual package for the inference and analysis of gene regulatory networksMarouen Ben Guebila, Tian Wang, Camila M Lopes-Ramos, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with SchizophreniaDalton King, Christiana Iwuagwu, Jim Cook, et al.
Pageof 6